Skip to main content

Showing 1–2 of 2 results for author: Fiorina, E

  1. Analysis methods for in-beam PET images in proton therapy treatment verification: a comparison based on Monte Carlo simulations

    Authors: M. Moglioni, A. C. Kraan, A. Berti, P. Carra, P. Cerello, M. Ciocca, V. Ferrero, E. Fiorina, E. Mazzoni, M. Morrocchi, F. Pennazio, A. Retico, V. Rosso, G. Sportelli, V. Vitolo, G. Bisogni

    Abstract: Background and purpose: In-beam Positron Emission Tomography (PET) is one of the modalities that can be used for in-vivo non-invasive treatment monitoring in proton therapy. PET distributions obtained during various treatment sessions can be compared in order to identify regions that have anatomical changes. The purpose of this work is to test and compare different analysis methods in the context… ▽ More

    Submitted 1 December, 2022; v1 submitted 10 October, 2022; originally announced October 2022.

    Comments: 9 pages, 5 figures

  2. arXiv:2010.16251  [pdf, other

    physics.ins-det nucl-ex

    The FragmentatiOn Of Target Experiment (FOOT) and its DAQ system

    Authors: Silvia Biondi, Andrey Alexandrov, Behcet Alpat, Giovanni Ambrosi, Stefano Argirò, Rau Arteche Diaz, Nazarm Bartosik, Giuseppe Battistoni, Nicola Belcari, Elettra Bellinzona, Maria Giuseppina Bisogni, Graziano Bruni, Pietro Carra, Piergiorgio Cerello, Esther Ciarrocchi, Alberto Clozza, Sofia Colombi, Giovanni De Lellis, Alberto Del Guerra, Micol De Simoni, Antonia Di Crescenzo, Benedetto Di Ruzza, Marco Donetti, Yunsheng Dong, Marco Durante , et al. (70 additional authors not shown)

    Abstract: The FragmentatiOn Of Target (FOOT) experiment aims to provide precise nuclear cross-section measurements for two different fields: hadrontherapy and radio-protection in space. The main reason is the important role the nuclear fragmentation process plays in both fields, where the health risks caused by radiation are very similar and mainly attributable to the fragmentation process. The FOOT experim… ▽ More

    Submitted 29 October, 2020; originally announced October 2020.